Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration‐Resistant Prostate Cancer
Meghana Yellanki,
Jennifer La,
Danne C. Elbers,
Nhan V. Do,
Channing J. Paller,
Nathanael R. Fillmore,
Martin W. Schoen
Wiley ·
2026-11-14
· DOI 10.1002/pros.70247
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Meghana Yellanki, Jennifer La, Danne C. Elbers, Nhan V. Do, Channing J. Paller, Nathanael R. Fillmore et al. Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration‐Resistant Prostate Cancer. // Prostate. – 2026. – DOI: 10.1002/pros.70247. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pros.70247?af=R
Meghana Yellanki, Jennifer La, Danne C. Elbers, Nhan V. Do, Channing J. Paller, Nathanael R. Fillmore, & Martin W. Schoen (2026). Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration‐Resistant Prostate Cancer. Prostate. https://doi.org/10.1002/pros.70247
Meghana Yellanki, et al. “Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration‐Resistant Prostate Cancer.” Prostate, 2026. doi:10.1002/pros.70247.
@article{Yellanki2026,
title = {Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration‐Resistant Prostate Cancer},
author = {Yellanki, Meghana and La, Jennifer and Elbers, Danne C. and Do, Nhan V. and Paller, Channing J. and Fillmore, Nathanael R. and Schoen, Martin W.},
journal = {Prostate},
year = {2026},
doi = {10.1002/pros.70247},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pros.70247?af=R}
}